Wegovy to become preferred GLP-1 drug on CVS Caremark's top formularies in 2025 as Novo Nordisk expands patient access ...

CVS said it will expand access to blockbuster weight loss drug Wegovy for patients covered by its pharmacy benefit manager, Caremark.

Danish drugmaker Novo Nordisk (NOV: N) has secured a significant advantage in the high-stakes obesity drug market after ...

JB Pritzker speaks at a news conference about Medicaid health coverage on Feb. 28 ... according to Fortune. CVS Health, for instance, owns PBM CVS Caremark, while Cigna owns the PBM Express ...

Effective July 1, 2025, CVS Caremark will place Wegovy injection 2.4 mg as preferred on its commercial template formularies.

CVS Caremark has selected Novo Nordisk’s Wegovy as the preferred GLP-1 medication for its largest commercial template formularies, effective July 1. In March, Novo Nordisk launched NovoCare Pharmacy ...

Starting July 1, Wegovy will become the preferred GLP-1 for obesity treatment on CVS Caremark’s largest commercial template ...

Aetna is once again retreating from the Affordable Care Act market, while its parent company notched a deal with Danish ...

CVS Caremark, OptumRx, Express Scripts and other PBMs remained loyal to big-ticket brand-name pharmaceuticals such as Humira, in part because they enjoyed lucrative rebates from drugmakers.

CVS Health Corp.’s drug-benefits unit negotiated a deal to make Novo Nordisk A/S’s Wegovy more widely available to its ...

Wegovy and Zepbound are part of a wave of obesity medications known as GLP-1 receptor agonists that have soared in popularity ...

CVS also tapped Ed DeVaney to serve as permanent president of CVS Caremark, the healthcare giant’s pharmacy benefit manager, in February. Joyner had previously led the PBM.